2VG6 - JenaLib

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:549
 aligned with POL_HV1B1 | P03366 from UniProtKB/Swiss-Prot  Length:1447

    Alignment length:551
                                   609       619       629       639       649       659       669       679       689       699       709       719       729       739       749       759       769       779       789       799       809       819       829       839       849       859       869       879       889       899       909       919       929       939       949       959       969       979       989       999      1009      1019      1029      1039      1049      1059      1069      1079      1089      1099      1109      1119      1129      1139      1149 
           POL_HV1B1    600 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKL 1150
               SCOP domains d2vg6a1 A:1-429 automated matches                                                                                                                                                                                                                                                                                                                                                                                                            d2vg6a2 A:430-551 automated matches                                                                                        SCOP domains
               CATH domains 2vg6A01 A:1-90,A:116-156 HIV Type 1 Reverse Transcriptase, subunit A, domain 1            2vg6A02                  2vg6A01 A:1-90,A:116-1  56               2vg6A02 A:91-115,A:157-225  [code=3.30.70.270, no name defined]      2vg6A03 A:226-319  [code=3.30.70.270, no name defined]                                        2vg6A04 A:320-426  [code=3.30.70.270, no name defined]                                                     2vg6A05 A:427-551  [code=3.30.420.10, no name defined]                                                                        CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------RNase_H-2vg6A01 A:435-551                                                                                             Pfam domains
         Sec.struct. author ..........................hhhhhhhhhhhhhhhhhhh.eee...........eeeee....eeeee..hhhhhhh............hhhhh....eeeee....hhhhh..hhhhhhhhhee......--...eeee........hhhhhhhhhhhhhhhhhhhhh...eeee....eeeee..hhhhhhhhhhhhhhhhhhh...............ee..eee...eeee...........hhhhhhhhhhhhhhhh.......hhhhhhh.............hhhhhhhhhhhhhhhhh...ee........eeeeee.....eeeeee.....eee..ee........hhhhhhhhhhhhhhhhhhhhhh...eeee..hhhhhhhhhhhh........eee......................eeeeee........eeeee.......eeeee...hhhhhhhhhhhhhhhh...eeeeee.hhhhhhhhh.......hhhhhhhhhhhhhh.eeeeee........hhhhhh.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R------L-----------------------------------------------------Q----------------Q---------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------RT_POL  PDB: A:44-234 UniProt: 643-833                                                                                                                                                         -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------RNASE_H  PDB: A:434-551 UniProt: 1033-1156                                                                             PROSITE
                 Transcript ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                2vg6 A    1 PISPIETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINN--PGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNKGRQKVVPLTNTTNQKTELQAIYLALQDSGLEVNIVTDSQYALGIIQAQPDKSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKL  551
                                    10        20        30        40        50        60        70        80        90       100       110       120       130      |140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       500       510       520       530       540       550 
                                                                                                                                                                  137  |                                                                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                     140

Chain B from PDB  Type:PROTEIN  Length:401
 aligned with POL_HV1B1 | P03366 from UniProtKB/Swiss-Prot  Length:1447

    Alignment length:424
                                   613       623       633       643       653       663       673       683       693       703       713       723       733       743       753       763       773       783       793       803       813       823       833       843       853       863       873       883       893       903       913       923       933       943       953       963       973       983       993      1003      1013      1023    
           POL_HV1B1    604 IETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQ 1027
               SCOP domains d2vg6b_ B: automated matches                                                                                                                                                                                                                                                                                                                                                                                                             SCOP domains
               CATH domains 2vg6B01 B:1005-1090,B:1116-1156 HIV Type 1 Reverse Transcriptase, subunit A, domain 1 2vg6B02                  2vg6B01 B:1005-1090,B:1116-1156          2vg6B02 B:1091-1115,B:1157-1243  [code=3.30.70.270, no nam               e defined]    2vg6B03 B:1244-1318  [code=3.30.70.270,    no name defined]                2vg6B04 B:1319-1428  [code=3.30.70.27     0, no name defined]                                                  CATH domains
           Pfam domains (1) ----------------------------------------------------------RVT_1-2vg6B01 B:1063-1234                                                                                                                                                   ---RVT_thumb-2vg6B05 B:1238-1307                                         ---------RVT_connect-2vg6B03 B:1317-1419                                                                        --------- Pfam domains (1)
           Pfam domains (2) ----------------------------------------------------------RVT_1-2vg6B02 B:1063-1234                                                                                                                                                   ---RVT_thumb-2vg6B06 B:1238-1307                                         ---------RVT_connect-2vg6B04 B:1317-1419                                                                        --------- Pfam domains (2)
         Sec.struct. author ......................hhhhhhhhhhhhhhhhhh..eee..........eeeee......eeeee.hhhhhhhhhhhhhh........hhhhh.eeeeee..........hhhhhhhhhee..hhhhh....eeee.......hhhhhhhhhhhhhhhhhhhhhh...eeeee..eeeeee..hhhhhhhhhhhhhhhhhhhh.---------------...eehhhhh.............hhhhhhhhhhhhhhhhhh............---.............hhhhhhhhhhhhh..............eeeeeee...eeeeeee.....eeeeeee.-----..hhhhhhhhhhhhhhhhhhhhh....eeee..hhhhhhhhhhhhh......eeee...hhhhhhhh. Sec.struct. author
                 SAPs(SNPs) -----------------------------------------------------------------------------------------------------------------------------------------------------------------------R---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ---------------------------------------RT_POL  PDB: B:1044-1234 UniProt: 643-833                                                                                                                                                      -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript
                2vg6 B 1005 IETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMTKILEPFKKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGL---------------MGYELHPDKWTVQPIVLPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKL---TKALTEVIPLTEEAELELAENREILKEPVHGVYYDPSKDLIAEIQKQGQGQWTYQIYQEPFKNLKTGKYA-----HTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEYWQATWIPEWEFVNTPPLVKLWYQ 1428
                                  1014      1024      1034      1044      1054      1064      1074      1084      1094      1104      1114      1124      1134      1144      1154      1164      1174      1184      1194      1204      1214         -     |1234      1244      1254      1264      1274       | - |    1294      1304      1314      1324      1334      1344      1354|     1364      1374      1384      1394      1404      1414      1424    
                                                                                                                                                                                                                                          1214            1230                                                1282   |                                                                 1355  1361                                                                   
                                                                                                                                                                                                                                                                                                                  1286

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (2, 3)

CATH Domains (3, 9)

Pfam Domains (4, 7)

Gene Ontology (45, 45)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B (POL_HV1B1 | P03366)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0003887	DNA-directed DNA polymerase activity	Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a DNA template and a 3'hydroxyl group.
	GO:0003723	RNA binding	Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
	GO:0004523	RNA-DNA hybrid ribonuclease activity	Catalysis of the endonucleolytic cleavage of RNA in RNA-DNA hybrids to 5'-phosphomonoesters.
	GO:0003964	RNA-directed DNA polymerase activity	Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Catalyzes RNA-template-directed extension of the 3'- end of a DNA strand by one deoxynucleotide at a time.
	GO:0004190	aspartic-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile.
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0004519	endonuclease activity	Catalysis of the hydrolysis of ester linkages within nucleic acids by creating internal breaks.
	GO:0004533	exoribonuclease H activity	Catalysis of the exonucleolytic cleavage of RNA to 5'-phosphomonoester oligonucleotides in both 5' to 3' and 3' to 5' directions.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0008289	lipid binding	Interacting selectively and non-covalently with a lipid.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0004518	nuclease activity	Catalysis of the hydrolysis of ester linkages within nucleic acids.
	GO:0003676	nucleic acid binding	Interacting selectively and non-covalently with any nucleic acid.
	GO:0016779	nucleotidyltransferase activity	Catalysis of the transfer of a nucleotidyl group to a reactant.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0005198	structural molecule activity	The action of a molecule that contributes to the structural integrity of a complex or its assembly within or outside a cell.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0008270	zinc ion binding	Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
	GO:0015074	DNA integration	The process in which a segment of DNA is incorporated into another, usually larger, DNA molecule such as a chromosome.
	GO:0006310	DNA recombination	Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Intrachromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction.
	GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic	The chemical reactions and pathways involving the hydrolysis of internal 3',5'-phosphodiester bonds in one or two strands of ribonucleotides.
	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	The chemical reactions and pathways involving the hydrolysis of terminal 3',5'-phosphodiester bonds in one or two strands of ribonucleotides.
	GO:0006278	RNA-dependent DNA biosynthetic process	A DNA biosynthetic process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strand.
	GO:0075713	establishment of integrated proviral latency	A process by which the virus integrates into the host genome and establishes as a stable provirus or prophage.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0039526	modulation by virus of host apoptotic process	Any process in which a virus modulates the frequency, rate or extent of apoptosis of infected host cells.
	GO:0090305	nucleic acid phosphodiester bond hydrolysis	The nucleic acid metabolic process in which the phosphodiester bonds between nucleotides are cleaved by hydrolysis.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0039657	suppression by virus of host gene expression	Any process in which a virus stops, prevents, or reduces the frequency, rate or extent of gene expression in the host organism. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Some protein processing events may be included when they are required to form an active form of a product from an inactive precursor form.
	GO:0046718	viral entry into host cell	The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
	GO:0075732	viral penetration into host nucleus	The crossing by the virus of the host nuclear membrane, either as naked viral genome or for small viruses as an intact capsid.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
	GO:0019076	viral release from host cell	The dissemination of mature viral particles from the host cell, e.g. by cell lysis or the budding of virus particles from the cell membrane.
cellular component
	GO:0030430	host cell cytoplasm	The cytoplasm of a host cell.
	GO:0044174	host cell endosome	A membrane-bounded organelle that carries materials newly ingested by endocytosis. It passes many of the materials to host cell lysosomes for degradation.
	GO:0033644	host cell membrane	Double layer of lipid molecules as it encloses host cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins. The host is defined as the larger of the organisms involved in a symbiotic interaction.
	GO:0042025	host cell nucleus	A membrane-bounded organelle as it is found in the host cell in which chromosomes are housed and replicated. The host is defined as the larger of the organisms involved in a symbiotic interaction.
	GO:0020002	host cell plasma membrane	The plasma membrane surrounding a host cell.
	GO:0072494	host multivesicular body	A late endosome in which regions of the limiting host cell endosomal membrane invaginate to form internal vesicles; host membrane proteins that enter the internal vesicles are sequestered from the host cytoplasm.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0019028	viral capsid	The protein coat that surrounds the infective nucleic acid in some virus particles. It comprises numerous regularly arranged subunits, or capsomeres.
	GO:0019013	viral nucleocapsid	The complete protein-nucleic acid complex that is the packaged form of the genome in a virus particle.
	GO:0019012	virion	The complete fully infectious extracellular virus particle.
	GO:0055036	virion membrane	The lipid bilayer surrounding a virion.

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File

1ajv	HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006
1ajx	HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001
1axa	ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT
1bqm	HIV-1 RT/HBY 097
1bqn	TYR 188 LEU HIV-1 RT/HBY 097
1d4h	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435
1d4i	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425
1d4j	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370
1dlo	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1dw6	STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE
1ebk	STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 PROTEASE
1ebw	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322
1eby	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369
1ebz	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388
1ec0	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403
1ec1	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409
1ec2	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428
1ec3	HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367
1eet	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
1hbv	HIV-1 PROTEASE COMPLEXED WITH SB203238
1hef	HIV-1 PROTEASE COMPLEXED WITH SKF 108738 ( HEF)
1heg	HIV-1 PROTEASE COMPLEXED WITH SKF 107457 ( HEG)
1hih	HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820
1hmv	HIV-1 REVERSE TRANSCRIPTASE
1hni	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S)
1hnv	HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED BY SER (C280S )
1hos	HIV-1 PROTEASE COMPLEX WITH SB204144
1hps	HIV-1 PROTEASE COMPLEXED WITH SB206343
1hpz	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1hqe	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1hqu	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
1hrh	RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE
1hte	HIV-1 PROTEASE COMPLEXED WITH GR123976
1htf	HIV-1 PROTEASE COMPLEXED WITH GR126045
1htg	HIV-1 PROTEASE COMPLEXED WITH GR137615
1hvk	HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S,S)
1hvp	HIV-1 PROTEASE COMPLEX WITH SUBSTRATE ( THEORETICAL MODEL)
1hvu	HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT
1hys	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A POLYPURINE TRACT RNA:DNA
1ikv	K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ
1ikw	WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ
1ikx	K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE INHIBITOR PNU142721
1iky	HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194
1j5o	CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV -1 REVERSETRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER
1mer	HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450
1mes	HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323
1met	HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323
1meu	HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323
1n5y	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX P)
1n6q	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA ( COMPLEX N)
1qe1	CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
1qmc	C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES
1r0a	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED TO DNA TEMPLATE -PRIMER SOLVED TO 2.8 ANGSTROMS
1rdh	HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN)
1rtd	STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
1rvl	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH ALPHA-APA (R89439) ( THEORETICAL MODEL)
1rvm	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH HEPT (THEORETICAL MODEL)
1rvn	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH PHENYL-ISOINDOLINONE ( THEORETICAL MODEL)
1rvo	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH NEVIRAPINE (THEORETICAL MODEL)
1rvp	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH THIAZOLOISOINDOLINONE ( THEORETICAL MODEL)
1rvq	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH TIBO (THEORETICAL MODEL)
1rvr	REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH IMIDAZODIPYRIDODIAZEPINE (UK -129,485) (THEORETICAL MODEL)
1s6p	CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
1s6q	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R147681
1s9e	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R129385
1s9g	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R120394.
1sbg	HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386
1suq	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R185545
1sv5	CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
1t03	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED TEMPLATE-PRIMER (COMPLEX P)
1t05	HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMERWITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE
1tv6	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707
1tvr	HIV-1 RT/9-CL TIBO
1uwb	TYR 181 CYS HIV-1 RT/8-CL TIBO
1w5v	HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1w5w	HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1w5x	HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
1w5y	HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL-BASED C2-SYMMETRIC INHIBITOR
2b5j	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R165481
2b6a	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH THR-50
2ban	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH JANSSEN- R157208
2be2	CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX WITH R221239
2hmi	HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE-STRANDED DEOXYRIBONUCLEIC ACID AND FAB28
2uxz	TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
2uy0	TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION-STATE MIMIC
2vg5	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS
2vg7	CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON- NUCLEOSIDE INHIBITORS
3hvt	REVERSE TRANSCRIPTASE
3tlh	STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN EFFICIENT INHIBITOR OF FIV PR

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 1)

Sites (1, 1)

SS Bonds (0, 0)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (5, 6)

PROSITE Motifs (2, 3)

Exons (0, 0)

Sequences/Alignments